FY20 Results Presentation
Filed with ASX · · 22 pages · English
This presentation has been prepared by Atomo Diagnostics Limited (“Atomo”) based on information available as at the date of this presentation. The information in this presentation is provided in summary form and does not contain all information necessary to make an investment decision. Reliance should not be placed on the information or opinions contained in this presentation. An investor must not
In the deck
Earlier from Atomo Diagnostics
- Atomo receives TGA approval for COVID19 antibody test
- Atomo & Access Bio enter North American COVID-19 partnership
- Quarterly Activity Report & Appendix 4C - 30 June 2020
- S&P DJI Announces June 2020 Quarterly Rebalance
- Atomo and NG Biotech expand COVID-19 partnership
Later from Atomo Diagnostics
- DIVOC Labs to sell Atomos COVID-19 test in India
- Atomo & Access Bio sign deal for rapid antigen test
- Atomo receives TGA approval for COVID19 antigen test
- Quarterly Activity Report & Appendix 4C - 30 September 2020
- Managing Directors AGM Presentation
Follow Atomo Diagnostics into a list and get an email when it puts out news.
Follow Atomo Diagnostics